Missing/wrong data?
Log in to edit
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial.
scientific article published on 14 December 2016
Author/s
author: Xavier Roblin, Pille Harrison, Stefan Schreiber, Maria Wisniewska-Jarosinska, Séverine Vermeire
Work details
Publication date
December 15, 2016
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.